A detailed history of First Financial Corp transactions in Amgen Inc stock. As of the latest transaction made, First Financial Corp holds 325 shares of AMGN stock, worth $102,995. This represents 0.05% of its overall portfolio holdings.

Number of Shares
325
Previous 369 11.92%
Holding current value
$102,995
Previous $115,000 9.57%
% of portfolio
0.05%
Previous 0.06%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$309.38 - $337.38 $13,612 - $14,844
-44 Reduced 11.92%
325 $104,000
Q2 2024

Jul 11, 2024

SELL
$262.75 - $319.31 $5,517 - $6,705
-21 Reduced 5.38%
369 $115,000
Q1 2024

Apr 12, 2024

BUY
$268.87 - $324.56 $14,250 - $17,201
53 Added 15.73%
390 $110,000
Q2 2023

Jul 14, 2023

SELL
$214.27 - $253.37 $5,571 - $6,587
-26 Reduced 7.16%
337 $74,000
Q1 2023

Apr 17, 2023

SELL
$225.79 - $275.2 $19,869 - $24,217
-88 Reduced 19.51%
363 $87,000
Q3 2021

Oct 18, 2021

SELL
$212.27 - $248.7 $10,613 - $12,435
-50 Reduced 9.98%
451 $96,000
Q1 2021

Apr 15, 2021

SELL
$221.91 - $258.6 $12,426 - $14,481
-56 Reduced 10.05%
501 $124,000
Q4 2020

Jan 15, 2021

SELL
$216.38 - $257.67 $11,468 - $13,656
-53 Reduced 8.69%
557 $128,000
Q3 2020

Oct 13, 2020

BUY
$234.65 - $260.95 $25,576 - $28,443
109 Added 21.76%
610 $155,000
Q2 2020

Jul 15, 2020

SELL
$197.81 - $242.74 $6,923 - $8,495
-35 Reduced 6.53%
501 $118,000
Q1 2020

Apr 15, 2020

SELL
$182.24 - $241.7 $3,462 - $4,592
-19 Reduced 3.42%
536 $108,000
Q3 2018

Oct 16, 2018

SELL
$185.29 - $208.89 $1,667 - $1,880
-9 Reduced 1.6%
555 $115,000
Q1 2018

Apr 17, 2018

SELL
$169.43 - $198.0 $25,075 - $29,304
-148 Reduced 20.79%
564 $97,000
Q4 2017

Jan 16, 2018

SELL
$168.79 - $188.59 $40,340 - $45,073
-239 Reduced 25.13%
712 $124,000
Q3 2017

Oct 13, 2017

BUY
$167.29 - $191.0 $159,092 - $181,641
951
951 $177,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $170B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track First Financial Corp Portfolio

Follow First Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Financial Corp , based on Form 13F filings with the SEC.

News

Stay updated on First Financial Corp with notifications on news.